Jay Bharat Maruti Ltd
JAYBARMARUJay Bharat Maruti Ltd is coiled. The quarters are improving, yet the P/E sits at the 15th percentile of its own 7-year range — the business is moving before the market.
The sharpest disagreement: annual EPS moved +324.3% against a +90.4% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (10 weeks in) while the P/E sits at the 15th percentile of its own 7-year range. Underneath, the last four quarters read improving — profit +281.0% year on year, and 285% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Jay Bharat Maruti Ltd trades at ₹161, in a confirmed uptrend and 10 weeks into that stage. That is +36.8% against its own 200-day average. It sits at 75% of a 52-week range of ₹81 to ₹188. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 17 straight weeks.
Today the stock is in a confirmed uptrend — week 10 of stage 2, confirmed. At ₹161 it trades +36.8% versus its 200-day average and sits at 75% of its 52-week range (₹81–₹188).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +574% while the NIFTY 500 moved +282% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 17 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Jay Bharat Maruti Ltd trades at 12.4× P/E, near the bottom of its own range — cheaper only 15% of the time. Its long-run median P/E is 20.1×, measured across 7.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 12.4× is near the bottom of its own range — cheaper only 15% of the time, against a long-run median of 20.1× measured over 7.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +324.3% against a +90.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +13.0%/yr price move, ~+22.7%/yr came from earnings growth and ~−9.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Jay Bharat Maruti Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.4% | +2.9% | +11.2% | — |
| Profit | +324.2% | +54.4% | +40.0% | — |
| EPS | +324.3% | +54.5% | +39.8% | — |
| Share price | +90.4% | +9.5% | +13.0% | +18.4% |
4-Factor Sector Score
72.1/100 — rank 2 of 20 in Auto Ancillaries - Diversified · 83% evidence confidence
Jay Bharat Maruti Ltd scores 72.1 out of 100 against the 20 companies it is compared with in Auto Ancillaries - Diversified, ranking 2. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 27.4 + 11.6 + 14.4 + 18.7 = 72.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Jay Bharat Maruti Ltd reported ₹766 Cr of revenue in the Mar 26 quarter, +25.4% year on year. That is the 6th straight quarter of year-on-year growth. Over 7 years it has compounded at 3.6% a year. The last full year, FY26, came in at ₹2,551 Cr. The last four reported quarters add to ₹2,551 Cr.
FY26 revenue came in at ₹2,551 Cr (+11.4% on the year), capping 7 years at 3.6% compound. The latest quarter (Mar 26) printed ₹766 Cr, +25.4% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +11.0% growth against the decade's 3.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +11.4% over the last 4 quarters against +5.5%/yr over the last 8 — accelerating; TTM profit +321.2% vs +108.4%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Jay Bharat Maruti Ltd's operating margin is 12.0% in the Mar 26 quarter, +3.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 8 fiscal years the operating margin has ranged 7.0% to 11.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 12.0%, +3.0 pp against the same quarter a year ago. Across 8 fiscal years the operating margin has ranged 7.0%–11.0%, and FY26's 11.0% is the top of that band — a record year.
Why the margin moved: operating margin went +2.4 pp year on year while gross margin went +0.6 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Jay Bharat Maruti Ltd earned ₹80.0 Cr of net profit in the Mar 26 quarter, +281.0% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹140 Cr. The 7-year compound rate is 15.2%. That is 10.4% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr.
Mar 26 profit was ₹80.0 Cr, +281.0% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹140 Cr (+324.2%), and the 7-year compound rate is 15.2%.
Why profit moved: revenue contributed +25.4% and the margin +3.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +372.8% vs revenue +11.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 285% of Jay Bharat Maruti Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹197 Cr of operating cash against ₹140 Cr of profit. After ₹148 Cr of capital spending, ₹49.0 Cr was left as free cash.
FY26: operating cash of ₹197 Cr against reported profit of ₹140 Cr, leaving free cash of ₹49.0 Cr after ₹148 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 285% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 285%: the cash cycle stretched 14 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 2.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Jay Bharat Maruti Ltd's cash conversion cycle runs 12 days in FY26, up from −2 days in FY21. Capital spending ran ₹642 Cr over the last 3 years. At FY26 sales of ₹2,551 Cr each day of that cycle holds about ₹7.0 Cr, so roughly ₹84.0 Cr sits inside the business at any moment.
FY26: debtors at 17 days, inventory at 52 days — roughly 1.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 12 days, looser than FY21's −2.
The full loop: cash goes out to suppliers and production on day 0; stock waits 52 days to sell; customers pay about 17 days after that; and suppliers themselves are paid at 57 days — netting out to the 12-day cycle.
In money terms: at FY26 sales of ₹2,551 Cr, each day of the cycle holds about ₹7.0 Cr — so the 12-day loop keeps roughly ₹84.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹642 Cr over the last 3 fiscal years against ₹263 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹110 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Jay Bharat Maruti Ltd earns a ROCE of 17% in FY26. That is up from a trough of 8% in FY25. Return on invested capital clears the cost of that capital by +3.3 percentage points, so growth here adds value rather than only size. The wiring behind it is 5.5% net margin on 1.39× asset turns.
FY26 ROCE is 17%, recovered from a FY25 trough of 8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 5.5% net margin × 1.39× asset turns × 2.63× balance-sheet leverage ≈ 20.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 15.3% − 12.0% = a +3.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Jay Bharat Maruti Ltd carries total debt of ₹531 Cr against shareholder equity of ₹696 Cr as of Mar 26, a debt-to-equity of 0.76. On the annual view that ratio went from 0.80 in FY22 to 0.76 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹531 Cr against shareholder equity of ₹696 Cr — a debt-to-equity of 0.76. On the annual view, debt-to-equity went from 0.80 (FY22) to 0.76 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Jay Bharat Maruti Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved +0.0 points over the same window, to 59.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +0.5 points over 8 quarters to 1.3%; Promoters: +0.0 points over 8 quarters to 59.4%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Jay Bharat Maruti Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1S J S Enterprises LtdSJS | 76.2/100Favorable setup93% evidence | LEADER | 27.8/35 Revenue 25.5% · PAT 44.5% · OPM change 4 pp 83% evidence | 21.3/25 ROCE 28.6% · OPM 29% 95% evidence | 9.7/20 P/E 45.1× · PEG 0.85 100% evidence | 17.4/20 RS sector 20.5% · RS bench 35.6% · 1Y 91.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 27.8 + 21.3 + 9.7 + 17.4 = 76.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Jay Bharat Maruti Ltdthis pageJAYBARMARU | 72.1/100Favorable setup83% evidence | BREAKING OUT | 27.4/35 Revenue 11.4% · PAT 100% · OPM change 3 pp 83% evidence | 11.6/25 ROCE 16.6% · OPM 12% 95% evidence | 14.4/20 P/E 12.4× · PEG — 50% evidence | 18.7/20 RS sector 34.6% · RS bench 50.4% · 1Y 121.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 27.4 + 11.6 + 14.4 + 18.7 = 72.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Automobile Corporation Of Goa LtdAUTOCORP | 68.6/100Favorable setup78% evidence | BREAKING OUT | 27.0/35 Revenue 41.1% · PAT 48.9% · OPM change 0 pp 83% evidence | 17.3/25 ROCE 29.6% · OPM 9% 76% evidence | 12.8/20 P/E 18.3× · PEG — 50% evidence | 11.5/20 RS sector -1.4% · RS bench 11.3% · 1Y 21.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 27 + 17.3 + 12.8 + 11.5 = 68.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Carraro India LtdCARRARO | 65.7/100Favorable setup89% evidence | FADING | 25.4/35 Revenue 24.8% · PAT 47.2% · OPM change 0 pp 88% evidence | 19.9/25 ROCE 29.5% · OPM 10% 100% evidence | 15.7/20 P/E 22.2× · PEG 0.66 65% evidence | 4.7/20 RS sector -9.1% · RS bench 2.8% · 1Y 10.5%6 of 12 weeks ahead 100% evidence |
| Exact sum: 25.4 + 19.9 + 15.7 + 4.7 = 65.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.1% and the one-year return is 10.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 5Lumax Auto Technologies LtdLUMAXTECH | 63.1/100Mixed-positive evidence96% evidence | ASLEEP | 26.2/35 Revenue 33.9% · PAT 47% · OPM change 0 pp 88% evidence | 18.1/25 ROCE 21.4% · OPM 14% 100% evidence | 12.2/20 P/E 37.2× · PEG 0.75 100% evidence | 6.6/20 RS sector -6.4% · RS bench 5.8% · 1Y 51.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 26.2 + 18.1 + 12.2 + 6.6 = 63.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.4% and the one-year return is 51.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 6Sansera Engineering LtdSANSERA | 58.8/100Mixed-positive evidence96% evidence | LEADER | 26.1/35 Revenue 15.9% · PAT 50.2% · OPM change 3 pp 88% evidence | 14.0/25 ROCE 14.1% · OPM 19% 100% evidence | 3.5/20 P/E 62.1× · PEG 2.22 100% evidence | 15.2/20 RS sector 41.5% · RS bench 58% · 1Y 146.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.1 + 14 + 3.5 + 15.2 = 58.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7OBSC Perfection LtdOBSCP | 58.0/100Mixed-positive evidence72% evidence | LEADER | 14.6/35 Revenue 0.1% · PAT 15.7% · OPM change 1.3 pp 71% evidence | 14.7/25 ROCE 19.5% · OPM 17.1% 95% evidence | 8.7/20 P/E 62.9× · PEG — 15% evidence | 20.0/20 RS sector 57.5% · RS bench 75.9% · 1Y 135.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.6 + 14.7 + 8.7 + 20 = 58 · Decision use: Price leads the evidence: RS versus the benchmark is 75.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Samvardhana Motherson International LtdMOTHERSON | 56.3/100Mixed-positive evidence96% evidence | LEADER | 15.1/35 Revenue 10.9% · PAT -1.4% · OPM change 2 pp 88% evidence | 10.9/25 ROCE 13.4% · OPM 11% 100% evidence | 13.9/20 P/E 37.3× · PEG 0.76 100% evidence | 16.4/20 RS sector 9.8% · RS bench 23.7% · 1Y 50.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 15.1 + 10.9 + 13.9 + 16.4 = 56.3 · Decision use: Price leads the evidence: RS versus the benchmark is 23.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Minda Corporation LtdMINDACORP | 55.9/100Mixed-positive evidence90% evidence | TURNING | 23.0/35 Revenue 22.3% · PAT 40.4% · OPM change 0 pp 88% evidence | 10.8/25 ROCE 12.7% · OPM 12% 100% evidence | 8.5/20 P/E 47.1× · PEG 1.58 100% evidence | 13.6/20 RS sector 1.8% · RS bench 20.5% · 1Y 37.2%9 of 11 weeks ahead 70% evidence |
| Exact sum: 23 + 10.8 + 8.5 + 13.6 = 55.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Bosch LtdBOSCHLTD | 54.0/100Mixed-positive evidence78% evidence | BREAKING OUT | 20.0/35 Revenue 10.8% · PAT 37.5% · OPM change 1 pp 83% evidence | 17.5/25 ROCE 21.5% · OPM 14% 76% evidence | 6.5/20 P/E 58× · PEG — 50% evidence | 10.0/20 RS sector -4.4% · RS bench 8.2% · 1Y 8.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 17.5 + 6.5 + 10 = 54 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 11Varroc Engineering LtdVARROC | 53.2/100Mixed-positive evidence83% evidence | TURNING | 17.1/35 Revenue 9% · PAT 100% · OPM change -2 pp 88% evidence | 11.7/25 ROCE 19% · OPM 9% 100% evidence | 15.1/20 P/E 41× · PEG 0.63 65% evidence | 9.3/20 RS sector -8.4% · RS bench 14.6% · 1Y 26.2%9 of 11 weeks ahead 70% evidence |
| Exact sum: 17.1 + 11.7 + 15.1 + 9.3 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Suprajit Engineering LtdSUPRAJIT | 51.7/100Mixed-positive evidence90% evidence | TURNING | 23.6/35 Revenue 16.7% · PAT 86.7% · OPM change 2 pp 88% evidence | 11.8/25 ROCE 16% · OPM 12% 100% evidence | 5.3/20 P/E 37× · PEG 5.51 100% evidence | 11.0/20 RS sector -2.4% · RS bench 10.2% · 1Y 8.2%8 of 11 weeks ahead 70% evidence |
| Exact sum: 23.6 + 11.8 + 5.3 + 11 = 51.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Endurance Technologies LtdENDURANCE | 49.4/100Mixed-negative evidence96% evidence | BREAKING OUT | 17.8/35 Revenue 26.3% · PAT 13.8% · OPM change 0 pp 88% evidence | 14.1/25 ROCE 17.8% · OPM 14% 100% evidence | 7.4/20 P/E 41.6× · PEG 2.74 100% evidence | 10.1/20 RS sector -8.5% · RS bench 3.7% · 1Y 6.9%9 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 14.1 + 7.4 + 10.1 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14NDR Auto Components LtdNDRAUTO | 48.7/100Mixed-negative evidence77% evidence | TURNING | 18.5/35 Revenue 15.4% · PAT 17% · OPM change 1 pp 83% evidence | 15.8/25 ROCE 22.2% · OPM 12% 95% evidence | 9.7/20 P/E 31.1× · PEG — 50% evidence | 4.7/20 RS sector -22.4% · RS bench -4.3% · 1Y -20.6%9 of 10 weeks ahead 70% evidence |
| Exact sum: 18.5 + 15.8 + 9.7 + 4.7 = 48.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Sharda Motor Industries LtdSHARDAMOTR | 47.1/100Mixed-negative evidence90% evidence | ASLEEP | 12.5/35 Revenue 19.8% · PAT 9.5% · OPM change -1 pp 88% evidence | 18.5/25 ROCE 36% · OPM 12% 100% evidence | 11.5/20 P/E 15.1× · PEG 2.02 100% evidence | 4.6/20 RS sector -16.8% · RS bench -6.9% · 1Y -18.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.5 + 18.5 + 11.5 + 4.6 = 47.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Motherson Sumi Wiring India LtdMSUMI | 40.0/100Mixed-negative evidence90% evidence | ASLEEP | 10.7/35 Revenue 23.1% · PAT 3% · OPM change -3 pp 88% evidence | 15.9/25 ROCE 38.9% · OPM 8% 100% evidence | 7.1/20 P/E 43.1× · PEG 6.28 100% evidence | 6.3/20 RS sector -6.9% · RS bench -6.5% · 1Y 0.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 10.7 + 15.9 + 7.1 + 6.3 = 40 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Munjal Auto Industries LtdMUNJALAU | 34.0/100Adverse evidence77% evidence | TURNING | 11.2/35 Revenue 11.1% · PAT 18.2% · OPM change -3.7 pp 83% evidence | 5.0/25 ROCE 11.1% · OPM 3% 95% evidence | 9.0/20 P/E 28.7× · PEG — 50% evidence | 8.8/20 RS sector -8.8% · RS bench 16% · 1Y 31.9%10 of 10 weeks ahead 70% evidence |
| Exact sum: 11.2 + 5 + 9 + 8.8 = 34 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18ZF Commercial Vehicle Control System India LtdZFCVINDIA | 33.8/100Adverse evidence100% evidence | BASING | 10.5/35 Revenue 9% · PAT 3.1% · OPM change 0 pp 100% evidence | 13.3/25 ROCE 19.4% · OPM 13% 100% evidence | 8.1/20 P/E 54.5× · PEG 4.2 100% evidence | 1.9/20 RS sector -81.5% · RS bench 0.8% · 1Y -82.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.5 + 13.3 + 8.1 + 1.9 = 33.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Precision Camshafts LtdPRECAM | 30.9/100Adverse evidence77% evidence | ASLEEP | 9.7/35 Revenue -10.6% · PAT -5.6% · OPM change 0 pp 83% evidence | 8.0/25 ROCE 7.3% · OPM 13% 95% evidence | 9.6/20 P/E 54.1× · PEG — 50% evidence | 3.6/20 RS sector -32% · RS bench -13.9% · 1Y -25.4%6 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 8 + 9.6 + 3.6 = 30.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Mercury EV-Tech LtdMERCURYEV | 23.8/100Adverse evidence70% evidence | TURNING | 8.3/35 Revenue 13.9% · PAT -47.2% · OPM change -8.7 pp 83% evidence | 3.5/25 ROCE 2.6% · OPM -11.6% 95% evidence | 8.5/20 P/E 159× · PEG — 15% evidence | 3.5/20 RS sector -39% · RS bench -8.8% · 1Y -27.7%2 of 7 weeks ahead 70% evidence |
| Exact sum: 8.3 + 3.5 + 8.5 + 3.5 = 23.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Jay Bharat Maruti Ltd's share price today?
Jay Bharat Maruti Ltd trades at ₹161, +90.4% over the past year. The company is valued at ₹1,738 Cr. The stock sits at 75% of its 52-week range of ₹81–₹188, +36.8% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 10 weeks in. — as of 31 July 2026.
What were Jay Bharat Maruti Ltd's latest quarterly results?
Jay Bharat Maruti Ltd reported revenue of ₹766 Cr and net profit of ₹80.0 Cr for the Mar 26 quarter. Revenue rose 25.4% and profit rose 281.0% year on year. Earnings per share were ₹7.35. The operating margin was 12.0%, 3.0 pp higher than a year earlier. — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's revenue?
Jay Bharat Maruti Ltd reported revenue of ₹766 Cr in the Mar 26 quarter, +25.4% year on year. For the full FY26 fiscal year, revenue was ₹2,551 Cr (+11.4%). Over the last 7 years revenue compounded at 3.6% a year. — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's profit?
Jay Bharat Maruti Ltd earned ₹80.0 Cr of net profit in the Mar 26 quarter, +281.0% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹140 Cr. The operating margin ran 12.0% in the latest quarter. — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's market cap?
Jay Bharat Maruti Ltd's market capitalisation is ₹1,738 Cr at a share price of ₹161. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's P/E ratio?
Jay Bharat Maruti Ltd trades at a P/E of 12.4×, at the 15th percentile of its own 7-year range, against a long-run median of 20.1×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Jay Bharat Maruti Ltd pay a dividend?
Yes — Jay Bharat Maruti Ltd's dividend payout was 5% of profit in FY26, and it recorded a payout in each of its last 8 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Jay Bharat Maruti Ltd overvalued?
On its own history, Jay Bharat Maruti Ltd looks cheap against its own history: its P/E of 12.4× has been cheaper only 15% of the time in 7 years (long-run median 20.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 31 July 2026.
Is Jay Bharat Maruti Ltd growing?
Yes — Jay Bharat Maruti Ltd is growing: latest-quarter revenue +25.4% year on year, profit +281.0%, and the margin +3.0 pp at 12.0%. The 7-year compound rates are 3.6% (revenue) and 15.2% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Jay Bharat Maruti Ltd performing?
Jay Bharat Maruti Ltd is in a confirmed uptrend, 10 weeks in. Its latest quarter's revenue rose 25.4% and profit rose 281.0% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 17 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Jay Bharat Maruti Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 10 of stage 2), trading +36.8% versus its 200-day average and at 75% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Jay Bharat Maruti Ltd beating the market?
On recent form, yes — Jay Bharat Maruti Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 17 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +574% against the NIFTY 500's +282% — ahead of the index over the full window. — as of 31 July 2026.
Will Jay Bharat Maruti Ltd's share price go up?
This page publishes no price forecast for Jay Bharat Maruti Ltd. What it measures instead: the share price is ₹161, the price is in a confirmed uptrend 10 weeks in. Its P/E of 12.4× sits at the 15th percentile of its own 7-year range. — as of 31 July 2026.
Who owns Jay Bharat Maruti Ltd?
Promoters hold 59.4% of Jay Bharat Maruti Ltd, foreign institutions 1.3%, domestic institutions 0.0% and the public 39.3% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Jay Bharat Maruti Ltd have too much debt?
It is moderate — Jay Bharat Maruti Ltd's debt-to-equity is 0.76, and operating profit covers the interest bill 6×. FY26 borrowings were ₹531 Cr against equity of ₹696 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's capex?
Jay Bharat Maruti Ltd spent ₹642 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹148 Cr, with ₹110 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Jay Bharat Maruti Ltd's cash flow?
Jay Bharat Maruti Ltd generated ₹197 Cr of operating cash flow in FY26 and ₹49.0 Cr of free cash flow after ₹148 Cr of capital spending. Reported profit that year was ₹140 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Jay Bharat Maruti Ltd's profit real cash?
Yes — over the last 3 fiscal years, 285% of Jay Bharat Maruti Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹197 Cr against reported profit of ₹140 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Jay Bharat Maruti Ltd in its business cycle?
Jay Bharat Maruti Ltd's FY26 operating margin was 11.0%, against a 8-year band of 7.0%–11.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 12.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Jay Bharat Maruti Ltd story?
The sharpest disagreement: annual EPS moved +324.3% against a +90.4% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Jay Bharat Maruti Ltd a stock worth studying right now?
This is not investment advice. The machine read: Jay Bharat Maruti Ltd is coiled. The quarters are improving, yet the P/E sits at the 15th percentile of its own 7-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.